Background
==========

Polymyositis (PM) and dermatomyositis (DM) are characterised by symmetrical muscle weakness, inflammatory infiltrates in skeletal muscle tissue and skin rash (DM).

Objective
=========

Our aim was to investigate the effects of high-dose intravenous immunoglobulin (IVIg) treatment of PM/DM patients on expression of various immunological markers in skeletal muscle tissue, e.g. major histocompatibility complex (MHC) class I and macrophages; on clinical signs; and on muscle status.

Methods
=======

Six PM and four DM patients were treated intravenously with high-dose IVIg. Skeletal muscle biopsies were collected from these patients on three occasions: before treatment, and 24--48 hours and 3 months after treatment. Consecutive sections immunohistochemically stained for HLA-ABC and CD163 were analysed both manually by conventional microscope and by computerized image analysis. The percentage of positively stained areas and the number of cells per mm^2^ were assessed.

Results
=======

The skeletal muscle tissue of IVIg-treated PM/DM patients revealed a heterogeneous change and covariation in expression of MHC class I and macrophages. Correlations with clinical parameters and muscle function will be determined.

Conclusions
===========

IVIg treatment affects the expression of MHC class I and CD163 positive macrophages in skeletal muscle tissue of PM/DM patients in a heterogenous and covarying fashion.
